Clinical Evaluation of a Normoproteic Diet

Vegenat, S.A.60 enrolled

Overview

The main objective of this trial is the clinical evaluation of a normoproteic diet, when this diet is used for total enteral nutrition in geriatric people. For 3 months,all the participants in the study will receive only tube feeding: The experimental group will receive the commercial preparation to evaluate (T-Diet Plus ®, Vegenat SA) and the control group will receive a standard diet (Jevity ®, Abbott Laboratories).

The project includes: * Product tolerance study: gastrointestinal and metabolic complications related to the product administration. * The monitoring of the intervention, and clinical and nutritional evaluation of the participants, including anthropometry, quality of life related to the health and clinical and nutritional status analytical evaluation (hematology and biochemistry). * The determination of the major biochemical variables related to the lipid profile and assessment of the antioxidant defense system, and also certain markers of metabolic syndrome and associated cardiovascular risk.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Severe Insufficient Nutrition

Interventions

T-Diet plus StandardDIETARY_SUPPLEMENT

T-Diet plus Standard is a complete balanced protein and energy oral nutrition supplement, indicated for the dietary management of patients with related malnutrition.

JevityDIETARY_SUPPLEMENT

JEVITY is a diet for tube-fed patients in the medium to long term, to varying degrees of malnutrition with gastrointestinal disorders.

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients over 65 years old, of both sex, receiving total enteral nutrition by tube. * Admitted to medically supervised institutions (homes, health centers). * Requirement for total enteral nutrition standard, at least 3 months. * Acceptance volunteer to participate in the study by signing the written informed consent (approved by the Ethics Committee of University Hospital Virgen de las Nieves). Exclusion Criteria: * Patients who receive drugs with lipid composition. * Unstable clinical situation. * Patients with terminal illness. * Refusal or physical or mental inability to cooperate in the study. * Participating in another study. * Other causes: social causes, humanitarian, non-cooperation, etc..

Locations (1)

Department of Biochemistry and Molecular Biology II. University of Granada

Granada, Granada, Spain

Outcomes

Primary Outcomes

Nutritional status evaluation

Clinical evaluation of a comercial product: T-Diet Plus (normoproteic and specific diet), when is used for total enteral nutrition in geriatric people.

Time frame: 6 months

Secondary Outcomes

Specific parameters measure

1. Confirm gastrointestinal and metabolic tolerance of the product. 2. Consider the influence of the diet received on quality of life related to health. 3. Study the changes in the nutritional status of elderly patients 4. Assess changes in the lipid profile of patients 5. Compare the evolution in blood levels of metabolic syndrome indicator parameters and other related to cardiovascular morbidity. 6. Assess changes in the antioxidant defense system.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.